Hizon Laboratories

What Hizon Laboratories does

Hizon Laboratories is a privately held pharmaceutical manufacturer based in Antipolo, Philippines, operating in the small-to-mid segment of the domestic drug-production industry. Per the firmographic data, the company manufactures oral-dosage pharmaceutical products — specifically syrups, tablets, and capsules — indicating it operates a conventional solid and liquid oral-dose manufacturing capability consistent with a contract manufacturer, generic-drug producer, or private-label/OTC supplier serving the Philippine market.

No further first-party information is available to characterize the business model, customer base, distribution channels, product portfolio, pricing, certifications, or ownership. The company's website (hizonlabs.com) returned only a loading/verification placeholder rather than substantive corporate content, and structured fields covering management, partnerships, funding, products, customers, and regulatory history are all empty in the input data. As a result, the company's competitive positioning, regulatory licensing footprint (e.g., Philippine FDA registration), export activity, and revenue model cannot be characterized from the supplied material. Any deeper analytical assessment should be deferred until at least a working website, a product catalog, and Philippine FDA registration records are obtained.

Name

Hizon Laboratories

Website

https://hizonlabs.com

Company type

Private

Headcount range

11–50 employees

Short description

Hizon Laboratories is a privately held pharmaceutical manufacturer in Antipolo, Philippines, producing syrups, tablets, and capsules for the domestic drug market. The firm employs 11-50 people and operates a small-scale oral-dose production facility.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical manufacturing
• Oral solid dosage
• Syrup production
• Tablet capsules
• Drug formulation

Headquarters

HQ city

Antipolo

HQ country

Philippines

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure

Core offering

Hizon Laboratories is a pharmaceutical manufacturing company based in Antipolo, Philippines that produces pharmaceutical dosage forms including syrups, tablets, and capsules. The company operates a small-scale (11-50 employees) manufacturing facility producing finished pharmaceutical products for distribution.

Product overview

No product or service information available. The source data contains only a site verification/loading page ("One moment, please...") with no substantive company content.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Syrups
• Pharmaceutical Tablets
• Pharmaceutical Capsules

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Natrapharm: Philippine pharmaceutical manufacturer of generic finished dosage forms including tablets, capsules, and syrups. Operates in the same domestic generic-pharma space as Hizon.
• Amherst Laboratories: Philippine-based pharmaceutical manufacturer producing generic tablets, capsules, and oral liquids. Comparable in product format, geography, and generic-pharma positioning.
• Lloyd Laboratories: Philippine pharmaceutical manufacturer focused on generic finished dosage forms (tablets, capsules, syrups, suspensions). Closely aligned with Hizon's FDF manufacturing model and target market.
• Pascual Laboratories: Philippine-based pharmaceutical manufacturer producing finished dosage forms including tablets, capsules, and syrups. Directly comparable as a domestic peer producing similar oral solid and liquid generics in the same geography.
• Myrex Pharma: Philippine pharmaceutical manufacturer producing generic tablets, capsules, and oral liquids. Directly comparable as a domestic FDF manufacturer serving the same customer base.

Regional players

• Hovid Berhad: Malaysian generic pharmaceutical manufacturer producing tablets, capsules, and oral dosage forms. Comparable as a regional Asian FDF manufacturer with similar generic-pharma positioning.
• Y.S.P. Industries: Malaysia-based pharmaceutical manufacturer producing generic finished dosage forms including tablets, capsules, and syrups. Comparable as a Southeast Asian FDF peer.

Broad incumbents

• United Laboratories (Unilab): The largest pharmaceutical company in the Philippines, producing a broad portfolio of finished dosage forms across multiple therapeutic categories. A broad incumbent against which smaller Philippine FDF manufacturers like Hizon compete.

Market position

Strengths2 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/hizon-laboratories-inc-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hizon Laboratories